Skip to search formSkip to main contentSkip to account menu

rivaroxaban

Known as: 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)- 1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide, 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide, Rivaroxaban [Chemical/Ingredient] 
An orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral… 
National Institutes of Health

Related topics

Related topics

15 relations

Narrower (2)

BAY 59-7939Xarelto

Broader (1)

Factor Xa inhibitors
In BloodRivaroxaban:ACnc:Pt:PPP:Qn:ChromoRivaroxaban:MCnc:Pt:PPP:Qn:ChromoRivaroxaban:MCnc:Pt:Ser/Plas:Qn

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Highly Cited
2018
Highly Cited
2018
Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation　- Findings From the SAKURA AF Registry.
BACKGROUND Although direct oral anticoagulants (DOACs) are widely used in Japanese patients with atrial fibrillation (AF), large… 
2018
2018
Anticoagulation therapy in SELECTeD cancer patients at risk of recurrence of venous thromboembolism : results of the 'select-d' Pilot Trial
2016
2016
Excess Mortality among Persons with Type 2 Diabetes.
2015
2015
Hemorrhagic complications of dental extractions in 181 patients undergoing double antiplatelet therapy.
Review
2012
Review
2012
Current guidelines for total joint VTE prophylaxis: dawn of a new day.
Venous thromboembolism (VTE) remains an immediate threat to patients following total hip and knee replacement. While there is a… 
Highly Cited
2012
Highly Cited
2012
Effect of rivaroxaban on blood coagulation using the viscoelastic coagulation test ROTEM™
This study investigated the influence of the oral direct inhibitor of factor Xa rivaroxaban on blood coagulation measured by… 
2012
2012
Do new oral anticoagulants require laboratory monitoring? The clinician point of view.
2011
2011
New options in anticoagulation for atrial fibrillation.
The presence of atrial fibrillation significantly increases the risk and burden of thromboembolic stroke.1 Warfarin is the… 
2009
2009
GLP-1 receptor agonists for type 2 diabetes
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)